US Patent 12128013 Toxic aldehyde related diseases and treatment
Patent 12128013 was granted and assigned to Aldeyra Therapeutics on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+87 properties)
Article (+463 characters)
US Patent 12128013 Toxic aldehyde related diseases and treatment
Article
Patent abstract
The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Kenneth J. Mandell0
Scott Young0
Todd Brady0
William A. Kinney0
Date of Patent
October 29, 2024
0Patent Application Number
182367950
Date Filed
August 22, 2023
0Patent Citations
0
Patent Primary Examiner
Find more entities like US Patent 12128013 Toxic aldehyde related diseases and treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
